triamcinolone has been researched along with Lymphoma, B-Cell, Marginal Zone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cotton, CH; Perman, MJ; Pillai, V; Reilly, AF; Skaljic, M | 1 |
| Carlson, JA; Ghatalia, P; Porter, J; Wroblewski, D | 1 |
| Hall, J; Hans, A; Kollipara, R; Lisle, A | 1 |
3 other study(ies) available for triamcinolone and Lymphoma, B-Cell, Marginal Zone
| Article | Year |
|---|---|
Complete resolution of primary cutaneous marginal zone B-cell lymphoma on the cheek of a 7-year-old boy with intralesional triamcinolone and tincture of time.
Topics: Cheek; Child; Glucocorticoids; Humans; Injections, Intralesional; Lymphoma, B-Cell, Marginal Zone; Male; Remission Induction; Skin Neoplasms; Time Factors; Triamcinolone; Watchful Waiting | 2020 |
Primary cutaneous marginal zone lymphoma associated with juxta-articular fibrotic nodules in a teenager.
Topics: Adolescent; Anti-Bacterial Agents; Borrelia burgdorferi; Borrelia Infections; Doxycycline; Drug Substitution; Fibrosis; Glucocorticoids; Humans; In Situ Hybridization; Joints; Lymphoma, B-Cell, Marginal Zone; Male; Skin Neoplasms; Treatment Outcome; Triamcinolone | 2013 |
A case report of primary cutaneous marginal zone lymphoma treated with intralesional steroids.
Topics: Anti-Inflammatory Agents; Arm; Biopsy; Eyebrows; Facial Neoplasms; Female; Humans; Injections, Intralesional; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Recurrence; Remission Induction; Skin Neoplasms; Triamcinolone | 2015 |